Startups
Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori). Recent advances in our understanding of fibroin biochemistry has allowed expansion of the versatility of the material into alternate physical formats such as hydrogels and implants loaded with active drug substances.
Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health. Cocoon’s first products are silk fibroin formulated with small molecules that target pain and inflammation in ophthalmology and osteoarthritis indications.
Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health. Cocoon’s first products are silk fibroin formulated with small molecules that target pain and inflammation in ophthalmology and osteoarthritis indications.
Overview
Location
United States, Minnesota, Cambridge
Employees
11-50
Founded date
2013
FAQ about Cocoon Biotech
When was Cocoon Biotech founded?
Cocoon Biotech was founded in 2013.
Is Cocoon Biotech still active?
Yes, Cocoon Biotech is active; its latest activity on Parsers VC dates from Oct 21, 2015.